世界の非侵襲的非経口スクリーニング市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4591 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、非侵襲的非経口スクリーニングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（器具、消耗品）、用途別市場規模（診断研究所、病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・非侵襲的非経口スクリーニングの市場動向 ・企業の競争状況、市場シェア ・非侵襲的非経口スクリーニングの種類別市場規模と予測2016-2027（器具、消耗品） ・非侵襲的非経口スクリーニングの用途別市場規模と予測2016-2027（診断研究所、病院） ・非侵襲的非経口スクリーニングの北米市場規模2016-2027（アメリカ、カナダ） ・非侵襲的非経口スクリーニングの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・非侵襲的非経口スクリーニングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非侵襲的非経口スクリーニングの中南米市場規模2016-2027（メキシコ、ブラジル） ・非侵襲的非経口スクリーニングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GE Healthcare、Philips、Illumina、Thermo Fisher Scientific、Roche、PacBio、Perkinelmer、Qiagen、Agilent Technologies、BGI Group） ・結論

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.

Market Analysis and Insights: Global Non-invasive Parenteral Screening Market
The global Non-invasive Parenteral Screening market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-invasive Parenteral Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-invasive Parenteral Screening market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-invasive Parenteral Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-invasive Parenteral Screening market.

Global Non-invasive Parenteral Screening Scope and Market Size
Non-invasive Parenteral Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-invasive Parenteral Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instruments
Consumables

Segment by Application
Diagnostic Laboratories
Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Non-invasive Parenteral Screening Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-invasive Parenteral Screening Market Perspective (2016-2027)
2.2 Non-invasive Parenteral Screening Growth Trends by Regions
2.2.1 Non-invasive Parenteral Screening Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-invasive Parenteral Screening Historic Market Share by Regions (2016-2021)
2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Regions (2022-2027)
2.3 Non-invasive Parenteral Screening Industry Dynamic
2.3.1 Non-invasive Parenteral Screening Market Trends
2.3.2 Non-invasive Parenteral Screening Market Drivers
2.3.3 Non-invasive Parenteral Screening Market Challenges
2.3.4 Non-invasive Parenteral Screening Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Parenteral Screening Players by Revenue
3.1.1 Global Top Non-invasive Parenteral Screening Players by Revenue (2016-2021)
3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2016-2021)
3.2 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
3.4 Global Non-invasive Parenteral Screening Market Concentration Ratio
3.4.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2020
3.5 Non-invasive Parenteral Screening Key Players Head office and Area Served
3.6 Key Players Non-invasive Parenteral Screening Product Solution and Service
3.7 Date of Enter into Non-invasive Parenteral Screening Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Parenteral Screening Breakdown Data by Type
4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2016-2021)
4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2022-2027)

5 Non-invasive Parenteral Screening Breakdown Data by Application
5.1 Global Non-invasive Parenteral Screening Historic Market Size by Application (2016-2021)
5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-invasive Parenteral Screening Market Size (2016-2027)
6.2 North America Non-invasive Parenteral Screening Market Size by Type
6.2.1 North America Non-invasive Parenteral Screening Market Size by Type (2016-2021)
6.2.2 North America Non-invasive Parenteral Screening Market Size by Type (2022-2027)
6.2.3 North America Non-invasive Parenteral Screening Market Size by Type (2016-2027)
6.3 North America Non-invasive Parenteral Screening Market Size by Application
6.3.1 North America Non-invasive Parenteral Screening Market Size by Application (2016-2021)
6.3.2 North America Non-invasive Parenteral Screening Market Size by Application (2022-2027)
6.3.3 North America Non-invasive Parenteral Screening Market Size by Application (2016-2027)
6.4 North America Non-invasive Parenteral Screening Market Size by Country
6.4.1 North America Non-invasive Parenteral Screening Market Size by Country (2016-2021)
6.4.2 North America Non-invasive Parenteral Screening Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non-invasive Parenteral Screening Market Size (2016-2027)
7.2 Europe Non-invasive Parenteral Screening Market Size by Type
7.2.1 Europe Non-invasive Parenteral Screening Market Size by Type (2016-2021)
7.2.2 Europe Non-invasive Parenteral Screening Market Size by Type (2022-2027)
7.2.3 Europe Non-invasive Parenteral Screening Market Size by Type (2016-2027)
7.3 Europe Non-invasive Parenteral Screening Market Size by Application
7.3.1 Europe Non-invasive Parenteral Screening Market Size by Application (2016-2021)
7.3.2 Europe Non-invasive Parenteral Screening Market Size by Application (2022-2027)
7.3.3 Europe Non-invasive Parenteral Screening Market Size by Application (2016-2027)
7.4 Europe Non-invasive Parenteral Screening Market Size by Country
7.4.1 Europe Non-invasive Parenteral Screening Market Size by Country (2016-2021)
7.4.2 Europe Non-invasive Parenteral Screening Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Parenteral Screening Market Size (2016-2027)
8.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type
8.2.1 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application
8.3.1 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region
8.4.1 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-invasive Parenteral Screening Market Size (2016-2027)
9.2 Latin America Non-invasive Parenteral Screening Market Size by Type
9.2.1 Latin America Non-invasive Parenteral Screening Market Size by Type (2016-2021)
9.2.2 Latin America Non-invasive Parenteral Screening Market Size by Type (2022-2027)
9.2.3 Latin America Non-invasive Parenteral Screening Market Size by Type (2016-2027)
9.3 Latin America Non-invasive Parenteral Screening Market Size by Application
9.3.1 Latin America Non-invasive Parenteral Screening Market Size by Application (2016-2021)
9.3.2 Latin America Non-invasive Parenteral Screening Market Size by Application (2022-2027)
9.3.3 Latin America Non-invasive Parenteral Screening Market Size by Application (2016-2027)
9.4 Latin America Non-invasive Parenteral Screening Market Size by Country
9.4.1 Latin America Non-invasive Parenteral Screening Market Size by Country (2016-2021)
9.4.2 Latin America Non-invasive Parenteral Screening Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Parenteral Screening Market Size (2016-2027)
10.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type
10.2.1 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application
10.3.1 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country
10.4.1 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Philips
11.2.1 Philips Company Details
11.2.2 Philips Business Overview
11.2.3 Philips Non-invasive Parenteral Screening Introduction
11.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.2.5 Philips Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Non-invasive Parenteral Screening Introduction
11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.3.5 Illumina Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Non-invasive Parenteral Screening Introduction
11.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.5.5 Roche Recent Development
11.6 PacBio
11.6.1 PacBio Company Details
11.6.2 PacBio Business Overview
11.6.3 PacBio Non-invasive Parenteral Screening Introduction
11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.6.5 PacBio Recent Development
11.7 Perkinelmer
11.7.1 Perkinelmer Company Details
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.7.5 Perkinelmer Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Non-invasive Parenteral Screening Introduction
11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.8.5 Qiagen Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.9.5 Agilent Technologies Recent Development
11.10 BGI Group
11.10.1 BGI Group Company Details
11.10.2 BGI Group Business Overview
11.10.3 BGI Group Non-invasive Parenteral Screening Introduction
11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2016-2021)
11.10.5 BGI Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Global Non-invasive Parenteral Screening Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Non-invasive Parenteral Screening Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non-invasive Parenteral Screening Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Non-invasive Parenteral Screening Market Share by Regions (2016-2021)
Table 8. Global Non-invasive Parenteral Screening Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Non-invasive Parenteral Screening Market Share by Regions (2022-2027)
Table 10. Non-invasive Parenteral Screening Market Trends
Table 11. Non-invasive Parenteral Screening Market Drivers
Table 12. Non-invasive Parenteral Screening Market Challenges
Table 13. Non-invasive Parenteral Screening Market Restraints
Table 14. Global Non-invasive Parenteral Screening Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Non-invasive Parenteral Screening Market Share by Players (2016-2021)
Table 16. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Parenteral Screening as of 2020)
Table 17. Ranking of Global Top Non-invasive Parenteral Screening Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-invasive Parenteral Screening Product Solution and Service
Table 21. Date of Enter into Non-invasive Parenteral Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-invasive Parenteral Screening Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2016-2021)
Table 25. Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Non-invasive Parenteral Screening Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2016-2021)
Table 29. Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Non-invasive Parenteral Screening Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Non-invasive Parenteral Screening Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Non-invasive Parenteral Screening Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Non-invasive Parenteral Screening Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Non-invasive Parenteral Screening Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Non-invasive Parenteral Screening Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Non-invasive Parenteral Screening Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Non-invasive Parenteral Screening Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Non-invasive Parenteral Screening Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Non-invasive Parenteral Screening Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Non-invasive Parenteral Screening Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Non-invasive Parenteral Screening Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Non-invasive Parenteral Screening Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non-invasive Parenteral Screening Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Non-invasive Parenteral Screening Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Non-invasive Parenteral Screening Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Non-invasive Parenteral Screening Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Non-invasive Parenteral Screening Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Non-invasive Parenteral Screening Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Non-invasive Parenteral Screening Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2022-2027) & (US$ Million)
Table 61. GE Healthcare Company Details
Table 62. GE Healthcare Business Overview
Table 63. GE Healthcare Non-invasive Parenteral Screening Product
Table 64. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 65. GE Healthcare Recent Development
Table 66. Philips Company Details
Table 67. Philips Business Overview
Table 68. Philips Non-invasive Parenteral Screening Product
Table 69. Philips Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 70. Philips Recent Development
Table 71. Illumina Company Details
Table 72. Illumina Business Overview
Table 73. Illumina Non-invasive Parenteral Screening Product
Table 74. Illumina Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 75. Illumina Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Non-invasive Parenteral Screening Product
Table 79. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Non-invasive Parenteral Screening Product
Table 84. Roche Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. PacBio Company Details
Table 87. PacBio Business Overview
Table 88. PacBio Non-invasive Parenteral Screening Product
Table 89. PacBio Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 90. PacBio Recent Development
Table 91. Perkinelmer Company Details
Table 92. Perkinelmer Business Overview
Table 93. Perkinelmer Non-invasive Parenteral Screening Product
Table 94. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 95. Perkinelmer Recent Development
Table 96. Qiagen Company Details
Table 97. Qiagen Business Overview
Table 98. Qiagen Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 99. Qiagen Recent Development
Table 100. Agilent Technologies Company Details
Table 101. Agilent Technologies Business Overview
Table 102. Agilent Technologies Non-invasive Parenteral Screening Product
Table 103. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 104. Agilent Technologies Recent Development
Table 105. BGI Group Company Details
Table 106. BGI Group Business Overview
Table 107. BGI Group Non-invasive Parenteral Screening Product
Table 108. BGI Group Revenue in Non-invasive Parenteral Screening Business (2016-2021) & (US$ Million)
Table 109. BGI Group Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-invasive Parenteral Screening Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Global Non-invasive Parenteral Screening Market Share by Application: 2020 VS 2027
Figure 5. Diagnostic Laboratories Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Non-invasive Parenteral Screening Report Years Considered
Figure 8. Global Non-invasive Parenteral Screening Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Non-invasive Parenteral Screening Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Non-invasive Parenteral Screening Market Share by Regions: 2020 VS 2027
Figure 11. Global Non-invasive Parenteral Screening Market Share by Regions (2022-2027)
Figure 12. Global Non-invasive Parenteral Screening Market Share by Players in 2020
Figure 13. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Parenteral Screening as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Revenue in 2020
Figure 15. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2016-2021)
Figure 16. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2022-2027)
Figure 17. North America Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Non-invasive Parenteral Screening Market Share by Type (2016-2027)
Figure 19. North America Non-invasive Parenteral Screening Market Share by Application (2016-2027)
Figure 20. North America Non-invasive Parenteral Screening Market Share by Country (2016-2027)
Figure 21. United States Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Non-invasive Parenteral Screening Market Share by Type (2016-2027)
Figure 25. Europe Non-invasive Parenteral Screening Market Share by Application (2016-2027)
Figure 26. Europe Non-invasive Parenteral Screening Market Share by Country (2016-2027)
Figure 27. Germany Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Non-invasive Parenteral Screening Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Non-invasive Parenteral Screening Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Non-invasive Parenteral Screening Market Share by Region (2016-2027)
Figure 37. China Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Non-invasive Parenteral Screening Market Share by Type (2016-2027)
Figure 45. Latin America Non-invasive Parenteral Screening Market Share by Application (2016-2027)
Figure 46. Latin America Non-invasive Parenteral Screening Market Share by Country (2016-2027)
Figure 47. Mexico Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Non-invasive Parenteral Screening Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Non-invasive Parenteral Screening Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Non-invasive Parenteral Screening Market Share by Country (2016-2027)
Figure 53. Turkey Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Non-invasive Parenteral Screening Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 57. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 58. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 61. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 62. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 63. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 64. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 65. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---